Acrivon Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ACRV | CRDF | ALLR | APLM | BBOT | KZIA | |
|---|---|---|---|---|---|---|
| Market cap | 74.56M | 67.60M | 17.18M | 55.38M | 184.40M | 92.33M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -1.1 | -1.6 | -1.3 | -29.2 | -0.8 | -1,473.8 |
| Price/book | 0.9 | 2.2 | 4.9 | -12.8 | 0.6 | 2.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −17.73% | −61.33% | −7.38% | +71.38% | −81.29% | +5.21% |
| Today | +4.19% | +0.67% | −4.42% | −8.83% | −0.86% | 0.00% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All ACRV news ›Acrivon Therapeutics Inc Highlights Preclinical Data with Three Posters At Aacr Demonstrating Strong Acr-368 and Acr-2316 Synergies with Immune Checkpoint Inhibitors and Adc Payloads
Published on 04/17/2026 at 04:00 pm EDT The data will be presented at the AACR 2026 Annual Meeting being held in San Diego, CA. The posters can be found on the Acrivon website under ?Posters and Presentations?. Poster Presentation Details:…
Acrivon Therapeutics, Inc. Strengthens its Precision Medicine Therapeutics Capabilities with Launch of Internal CLIA-Certified Laboratory
Acrivon Therapeutics, Inc. announced the completion and certification of its internal, wholly-owned and operated Clinical Laboratory Improvement Amendment certified laboratory, located on premises in... announced the completion and…
Acrivon Therapeutics, Inc. Announces Appointment of Michaela Levin as Chief Business Officer, Effective August 31, 2026
Acrivon Therapeutics, Inc. announced the appointment of Michaela Levin, Ph.D., as chief business officer, effective August 31, 2026. Dr. Levin comes with a solid, broad background in biotechnology... announced the appointment of Michaela…
HC Wainwright & Co. reiterates Buy rating on Harmony Biosciences Hldgs, $55 price target
HC Wainwright & Co. reiterated their Buy rating on Harmony Biosciences Hldgs's stock with a price target of $55.00. The price target implies an upside of 43.9% from the Oct 12 close of $38.23. Strong Leadership Experience: The new CEO,…
Autolus Therapeutics (AUTL) Receives a Buy from Wells Fargo
In a report released on October 2, from Wells Fargo maintained a Buy rating on Autolus Therapeutics, with a price target of $5.00. The company’... In a report released on October 2, from Wells Fargo maintained a Buy rating on Autolus…
H.C. Wainwright Keeps Their Buy Rating on Autolus Therapeutics (AUTL)
In a report released today, Emily Bodnar from H.C. Wainwright maintained a Buy rating on Autolus Therapeutics, with a price target of $10.00. According to TipRanks, Bodnar is a 4-star analyst with an average return of 4.1% and a 37.75%…
Acrivon Therapeutics (NASDAQ:ACRV) Stock Rating Raised to “Hold” at Wall Street Zen
Posted by Kim Johansen on Oct 6th, 2026 Wall Street Zen upgraded shares of Acrivon Therapeutics (NASDAQ:ACRV – Free Report) from a sell rating to a hold rating in a report released on Monday,Wall Street Zen reports. View Our Latest…
Acrivon Therapeutics, Inc. and Akoya Biosciences Enter into Termination and Transition Agreement
On February 18, 2026, Acrivon Therapeutics, Inc. announced the completion and certification of its internally, wholly-owned and operated Clinical Laboratory Improvement Amendment certified... On February 18, 2026, Acrivon Therapeutics, Inc…
Acrivon Therapeutics, Inc. Advances Acr-7280, an Oral Cdk11 Inhibitor, Toward Investigational New Drug Filing
Acrivon Therapeutics, Inc. announced the advancement of ACR-7280, a potential first-in-class, oral CDK11 inhibitor, as its next development candidate generated from its AI-enabled AP3 innovation ... announced the advancement of ACR-7280, a…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com8
- markets.businessinsider.com2
- markets.financialcontent.com1
- themarketsdaily.com1
- tradingview.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 13 articles, not a forecast.